Trial Profile
Clinical Trials Insight: 700008789
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 Aug 2006
Price :
$35
*
At a glance
- Drugs Osemozotan (Primary)
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- 25 Aug 2006 Status change
- 24 Nov 2005 New trial record.